The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.
Also called NCT03551496
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 201 participants
- Sponsor
- Registry
-
NCT03551496
-
- Other papers using this trial's data
- Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, France, Japan, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT03551496. Randomized; single masking; primary purpose treatment. Start 2018-08-31 (actual); primary completion 2022-04-21 (actual). Results posted on 2023-08-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
- Acronym
- SAVAL
- Condition
- Critical Limb Ischemia
- Intervention (Combination product)
- Drug Eluting Stent - Below the Knee
- Intervention (Device)
- Standard PTA Control Arm
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct03551496- Content hash
df7cf993184b30a85804306c2e3fd8dbde19beddd7a04f28089635461b0658ee